Pending Review
In April 2024, the stablecoin issuer Tether invested $200 million via its Tether Evo venture arm to acquire a majority stake in Blackrock Neurotech.
Date: 2024-04-29
Added: 02 May 2026
Pending Review
The company's core technology, the Utah Array (also known as the NeuroPort Electrode), received Breakthrough Device Designation from the FDA in 2021 for its MoveAgain system.
Date: 2021
Added: 02 May 2026
Pending Review
In May 2021, Blackrock Neurotech closed a $10 million financing round led by Christian Angermayer's re.Mind Capital, with participation from Peter Thiel and the University Venture Fund II.
Date: 2021-05-19
Added: 02 May 2026
Pending Review
Blackrock Neurotech filed filing with the SEC on 2023-02-23. Accession number: N/A.
Date: 2023-02-23
Added: 12 Apr 2026